跳至主要内容
临床试验/CTRI/2024/09/074071
CTRI/2024/09/074071尚未招募不适用

Drug utilization evaluation of proton pump inhibitors in teaching hospital: A Prospective- longitudinal study.

未提供1 个研究点 分布在 1 个国家目标入组 296 人开始时间: 2024年10月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
296
试验地点
1
主要终点
Number of PPI prescribed at higher dose, frequency of drug interactions and ADRs associated with PPIs. Adherence to PPI deprescribing guidelines.

研究概览

简要总结

A prospective longitudinal study will be conducted at the Department of General Medicine. A literature review will be conducted followed by development of a Case Report Form. Upon receiving IEC approval, the Informed Consent (IC) and Patient Information Sheet (PIS) forms are prepared. With the necessary ethical approvals and consent forms in place, the data collection phase begins. This phase involves gathering both initial baseline data and follow-up data from participants. The next step involves assessing and identification of ADRs and detailed causality and severity assessment. The need for Deprescribing will be evaluated as per guidelines.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Patients prescribed with Proton Pump Inhibitors.

排除标准

  • Pregnant and lactating women Terminally ill patients.

结局指标

主要结局

Number of PPI prescribed at higher dose, frequency of drug interactions and ADRs associated with PPIs. Adherence to PPI deprescribing guidelines.

时间窗: 48 weeks

次要结局

  • Adherence to PPI deprescribing guidelines.(48 weeks)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Mohammed Adeeb

Manipal Academy of Higher Education

研究点 (1)

Loading locations...

相似试验